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Cervical pathology represents 10% to 15% of all gynecological
diseases in women of reproductive age.1-4 The emergence and
development of pathological processes in the cervix is a complex
process requiring further study. At the present time cervical cancer
is the most frequent malignant disease of the female genital sphere
in many countries. It represents approximately 12% of all malig-
nant tumors detected in women.5-7 At present, a viral hypothesis
is recognized as the key concept of etiology and pathogenesis
of cervical cancer in which the leading role is played by human
papillomavirus (HPV) infection.5,8 Great importance in the
emergence of cervical precancerous lesions is attributed to birth
trauma and cervical injury due to an induced abortion. Carcino-
genic effects of an abortion might be connected to mechanical
trauma of the endocervix and a possible infection. Thus, the eti-
ology and risk factors for cervical diseases remain not sufﬁciently
studied at present.8
The purpose of the study was to improve health care for women
with background and precancerous cervical diseases by optimizing
programs of diagnostic, preventive, therapeutic, and rehabilitative
measures.
Patients and Methods
We have studied the results of a complex examination and
treatment of 948 women with background and precancerous cer-
vical diseases and who were treated at the City Clinical Hospital 8,
Ufa, and in the Republican Oncology Centre. The study groupincluded 312 (33%) women with background and precancerous
cervical diseases associated with anogenital HPV infection, 306
(32%) with cervical dysplasia, 178 (19%) with cervical leukoplakia,
and 152 (16%) who had undergone subtotal hysterectomy. The
age of the patients varied from 17 to 65 years. The following
examination methods were used: clinical, ultrasound, endoscopic
(colposcopic), cytological, immunological, bacterioscopic, bacterio-
logical, polymerase chain reaction, histomorphologic with prepara-
tion of serial step sections, and deﬁnition of vaginal biocenosis.
The largest group comprised patients with HPV-associated back-
ground and precancerous cervical diseases. A molecular and bio-
logical method was used to identify viral DNA particles of HPV.
During bacterioscopic and bacteriological examination of patients,
the following accompanying microﬂora were revealed: gardnerella
(62.2%), ureaplasma and mycoplasma (59.6%), candida (34.6%),
chlamydia (16.4%), and trichomonas (12.5 %). Colposcopic ex-
amination was used to diagnose unﬁnished cervical transforma-
tion zone (79.6%), simple leukoplakia (11.8%), endometriosis
(4.4%), cervical intraepithelial neoplasia (CIN) I (3.2%), and CIN
II (1%). Optimization of diagnostic and therapeutic measures in
cervical HPV-associated background and precancerous diseases
was given in 3 stages. At the ﬁrst stage an etiotropic treatment of
reproductive system pathology is carried out with the use of anti-
bacterial drugs and probiotics. At the same time examination and
treatment of a partner was performed. Control of concurrent con-
ditions was executed via retaking a smear for bacterioscopic and
bacteriologic study. At the second stage, a radio wave destruction
of the cervix was performed using the “Surgitron” device (Ellman
International, Hicksville, NY). The third stage was rational man-
agement of the postsurgical period using ozonated olive oil (otri-
ozonide). The oil has an antibacterial and antiviral effect, and
stimulates reparative processes. Epithelialization of the wound sur-
face after radiofrequency excision of warts and diseased areas of
the cervix and application of ozonated olive oil was executed atClinical Ovarian and Other Gynecologic Cancer December 2013 - 7
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6 months and 1 year later, using videocolposcopy, swabs for atypical
cells, direct microscopic, and molecular biological (polymerase chain
reaction) study. Recurrence of genital warts 3 months later was
observed in 8 patients (2.5%). Background diseases of the cervix
(simple leukoplakia) were diagnosed in 7 (2.1%) cases. Thus, the
proposed program of diagnostic and therapeutic measures using the
radiowave method, use of antiviral antibiotic agents, immuno-
modulators, ozonated olive oil (otri-ozonide) ensured the effec-
tiveness of the genital wart treatment in 97.5% of cases and
background or precancerous cervical diseases in 98.4% of cases.
Cervical dysplasia is attributed to precancerous diseases. The
terms “cervical intraepithelial neoplasia” (CIN) and “squamous
intraepithelial lesion” (SIL) (proposed by the US National Institute
for Cancer Research) are used in foreign literature to refer to
dysplasia and preinvasive cancer. We have studied the results of
complex examination and treatment of 306 women with cervical
dysplasia aged from 18 to 65 years. The patients are presented in
2 groups. The comparison group consisted of 256 (84%) patients
who were treated according to current treatment settings. The main
group consisted of 50 (16%) women examined and treated with
the optimized program of diagnostic, therapeutic, and rehabilitative
measures. A complex assessment of the social risk factors for cervical
dysplasia showed that dysplasia was more frequently detected at the
age older than 35 years (74.5%); 12.7% of them had occupational
hazards. Smoking habits were taken into account in the study.
Comprehensive assessment of obstetrical risk factors for cervical
dysplasia showed that this pathology occurs more often in women
having 3 or more abortions (86.1%) in anamnesis. The study of
concomitant gynecological pathology revealed that all patients
(100%) had vaginitis of various etiologies in their medical history.
It was found that dysplasia occurs typically on a pathologically
modiﬁed cervix (63.5% leukoplakia, scar deformation in 43.4%).
In 37.2%, dysplasia occurs after an earlier treatment of the cervix
(diatermo surgery). Treatment of cervical dysplasia in the compar-
ative group was carried out using the following methods: dia-
termosurgical (diatermoconization, 60.4%); cryosurgical (12.6%);
laser surgical (22.5%); hysterectomy without appendages (4.5%)
due to combination of dysplasia with uterine ﬁbroid tumors. An
optimized program of diagnostic, medical, rehabilitation, and pre-
ventive measures consists of 3 stages. At the ﬁrst stage of the pre-
surgical period, a complex etiotropic therapy of the concomitant
genital pathology with inﬂammatory origin is carried out. In the
second stage, the differentiated approach to the choice of treatment
method is applied: if dysplasia is of mild or moderate degree then
the cone method of diatermo excision is used; or laser, ultrasound,
or radiowave conization, and the pathologically changed area should
be dissected out within the limits of healthy tissues. New technology
of reconstructive plastic surgery (our modiﬁcation) is used in cases
of vaginal wall prolapse or when the cervix is deformed by old deep
side breaks in parous women of reproductive age. Hysterectomy
without appendages or with appendages (depending on their con-
dition) is performed in the following cases: dysplasia on the back-
ground of sharply shortened scar-deformed cervix left as a result of
previous (multiple) treatment for background and precancerous
lesions and cervical dysplasia combined with uterine ﬁbroid tumors,
ovarian cyst, uterine prolapse, and pelvic ﬂoor relaxation. Thenical Ovarian and Other Gynecologic Cancer December 2013dysplasia of the cervical stump (after previous surgery of supra-
cervical uterus amputation) led to the extirpation of the cervical
stump. The treatment was carried out using the following methods:
laser conization 64% (n ¼ 32), cryoconization 10% (n ¼ 5),
reconstructive and plastic surgery 10% (n ¼ 5), hysterectomy 10%
(n ¼ 5), and extirpation of the cervical stump 6% (n ¼ 3). There
were no complications observed in the early postsurgical period.
Study of the cervical dysplasia treatment in the comparative group
after 6 months resulted in 8.9% of the patients who were diagnosed
as having a relapse. The number of relapses in the study group was
1.3% (P < .05). Relapses occurred after diatermo conization. Thus,
the use of a 3-stage system of treatment and preventive measures
in cases with cervical dysplasia can improve the treatment results
in this group of patients. One hundred seventy-eight patients had
leukoplakia of the cervix. They were divided into 2 groups: major
and comparative. In the major group (80 [45%] people) we applied
the optimized program of therapeutic, preventive, and rehabilitative
measures with use of laser therapy, reconstructive and plastic sur-
gery, and optimization of presurgical and postsurgical treatment. In
the comparison group (98 [55%] people) the treatment of leuko-
plakia was performed using high-intensity laser radiation in accor-
dance with generally accepted practices. Evaluation of laser surgery
treatment results in 98 (55%) patients from the comparison group
of patients was performed 3 months later. During the cervical ex-
amination using a vaginal speculum, subconical cervix (26%), cy-
lindrical cervix (74%), and scar deformation (21.6%) was found.
During colposcopic examination, a healthy cervix was found in 86
(87.8%) patients (87.8%). Recurrence of leukoplakia was diagnosed
in 12 (12.2%) patients on the background of a scar-deformed
cervix. All 12 women with a history of recurrent leukoplakia were
treated for background diseases with diatermo surgery 58% (n ¼ 7)
and laser surgery 42% (n ¼ 5). We have worked out an optimized
program of therapeutic, preventive, and rehabilitative measures
presented in 3 stages. The ﬁrst stage is a presurgical period that
includes a complex examination, sanitation of genital tract from
the identiﬁed causative agent in accordance with the current pro-
cedures, and performance of control bacterioscopic smear studies.
The second stage includes a differentiated approach to the choice
of treatment. Laser excision using the device “Lancet-2” (Kaluga
Medical and Technical Laser Centre, Kaluga, the Russian Federa-
tion) is used for simple leukoplakia. Reconstructive plastic surgery
on the cervix is used in leukoplakia together with hypertrophy,
elongation, and cervix strain due to old breaks. In the third stage,
to improve the reparative processes in the postsurgical period, 2 to 3
days after the radical treatment of cervical leukoplakia, intravaginal
suppositoria with methyluracil were used. Helium-neon laser irra-
diation is performed 2 to 3 days after the surgery (ULF-01 “Yagoda”
device [Kaluga Medical and Technical Laser Centre, Kaluga, the
Russian Federation]). A follow-up examination is carried out after
1 month (spoon-shaped vaginal speculums are used, and simple
colposcopic examination is executed). Treatment results of patients
with cervix leukoplakia in the study group were as follows: laser
excision was performed in 27 (34%) nonparous women with leu-
koplakia without atypia, laser conization was performed in 36
(45%) parous women with leukoplakia in combination with glan-
dular cervical muscle hypertrophy. In the hospital in 17 (21%)
women with combined pathology (leukoplakia, scar deformation,
Badretdinova F. Flarida et aland elongation of the cervix 59% [n ¼ 10], leukoplakia and glan-
dular hypertrophy of the cervix muscle 41% [n ¼ 7], including
combination with CIN I) who had undergone reconstructive plastic
surgery according to our method were found. Disease relapse was
diagnosed 3 months later in 4 (5%) patients after laser conization.
Laser surgical treatment was repeated and yielded favorable results.
Thus, the use of the optimization program for leukoplakia treat-
ment using new technologies of surgical treatment improved the
treatment results (number of relapses decreased from 12.2% to 5%;
P < .05).
Results
The results of a complex examination of 152 patients who un-
derwent subtotal hysterectomy due to uterine ﬁbroid tumors were
studied. The average age was 46.5  0.42 years. During the col-
poscopic examination, 93 (61.2%) women were diagnosed with
pathology of cervical stump; an unﬁnished transformation zone
(52.0%), simple leukoplakia (21.3%), atypical leukoplakia (3.9%),
unﬁnished transformation zone on the background of a scar-
modiﬁed cervix (6.8%), ﬁbroid of the cervical stump (3.9%), de-
cubitus ulcer (4.8%), endometriosis (3.5%), CIN I (1.9%), and
CIN II (1.9%). Twenty women (13.2%) were diagnosed with
cancer of the cervical stump. The indications for subtotal hyster-
ectomy for 20 women in this subgroup were: uterine ﬁbroid tumors
80% (n ¼ 16), and a combination of nonmalignant ovarian and
uterine ﬁbroid tumors 20% (n ¼ 4). Time from subtotal hyster-
ectomy to cervical stump cancer diagnosis was: up to 3 years 20%
(n ¼ 4), from 4 to 10 years 80% (n ¼ 16). Cancer stage IIB was
established in 12 (60%) patients, stage III in 6 (30%), and stage IV
in 2 (10%) women. Eighteen patients (90%) with cervisal stump
cancer underwent combined radiation therapy, and 2 patients (with
stage IV cancer) had palliative treatment. Thirty-nine (25.6%)
women who underwent subtotal hysterectomy with appendages
were diagnosed with having postoophorectomy syndrome. Laser
surgery, cryosurgery, and radiowave methods were applied to treat
the revealed pathology of cervical stump. Extirpation of the cervical
stump (transabdominal and transvaginal access) was used for
dysplasia, leukoplakia with basal cell atypia, eroded ectropion with
scar deformation of the cervical stump, hyperplastic processes in the
mucosa of the cervical canal, ﬁbroid tumor of the cervical stump,
and prolapse of the cervical stump and vaginal walls. Examination
of the control subjects 6 months after treatment revealed a recur-
rence of leukoplakia in 2 (1.9%) women after laser conization and
who therefore had to undergo extirpation of the cervical stump
via transvaginal access. Relapse of cervical stump pathologies after
laser destruction 6 months later were not found.
Discussion
In concurrent pathology (n ¼ 312) (the background and pre-
cancerous cervical diseases and genital HPV) the application of an
optimized 3-stage program of diagnostic, therapeutic, and rehabil-
itative measures using the radiowave method (“Surgitron” device)
and application in the postsurgical period of ozonated olive oil (otri-
ozonide) yielded positive results in 98.8% of the patients.
The risk criteria of development of cervical intraepithetlial
neoplasia were: women older than 35 years, a smoking habit, and
with obstetric and gynecological anamnesis burden (medicalabortions, obstetric cervical traumas during childbirth resulting with
scar deformation, leukoplakia, or malfunction of vaginal bioce-
nosis). Application of the optimized program of diagnostic, thera-
peutic, and rehabilitation measures allowed improvement of the
results in the CIN treatment group—a decrease in number of re-
lapses in 6 months from 8.9% to 1.3% (P < .05).
Application of the optimized program of diagnostic, therapeutic,
and rehabilitation measures in cervical leukoplakia statistically and
reliably allowed a decrease in the number of relapses from 12.12%
to 5% (P < .05).Conclusion
The examination of 152 women 3 to 10 years after subtotal
hysterectomy revealed 92.3% with background and 7.7% with
precancerous diseases of cervical stump; 20 patients had cervical
cancer (treated in the Oncology Center). The application of the
optimized program of diagnostic, treatment, and rehabilitation
measures allowed positive results in 98.1% of patients with back-
ground diseases of the cervical stump.
Clinical Practice Points
 Cervical cancer is currently the most frequent oncologic disease
of female genital sphere in many countries of the world. An
important role in the occurrence of cervical precancerous lesions
is played by birth trauma and injury of the cervix in artiﬁcial
abortion. At the present moment a viral hypothesis is recognized
as the key concept of etiopathogenesis of cervical cancer where
the leading role is played by human papillomavirus infection.
The issues of etiology and risk factors for cervical disease
currently remain to be not studied enough. The occurrence and
development of pathological processes in the cervix is a
complicated and lengthy process.
 In our study we worked out the risk criteria for the develop-
ment of cervical intraepithelial neoplasia: women over 35 who
smoke, have burdened obstetric and gynecological history
(medical abortion, obstetric cervical trauma during the birth
giving, followed by the development of scar deformation, leu-
koplakia, problems in vaginal biocenosis). We also worked out
the program of optimization of diagnostic, therapeutic, pre-
ventive and rehabilitation measures taking into account the
nature of cervical pathology and differentiated approach to the
choice of treatment. The individual approach to the selection
of organ saving or radical treatment using new surgery tech-
nologies was deﬁned. The application of optimized diagnostic,
rehabilitation and treatment programs in patients with com-
bined pathology of background and precancerous cervical
diseases and human papillomavirus infection, cervical leuko-
plakia, cervical intraepithelial neoplasia, with background and
precancerous diseases of the cervical stump allowed us to
improve the treatment outcome, reduce the number of re-
currences and obtain signiﬁcant results. The optimization of
medical care for women having cervical pathology is secondary
prevention of cervical cancer.
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